About Us
The Division of Malignant Hematology and Medical Oncology brings together clinical, research, and behavioral medicine faculty dedicated to advancing cancer care through expert treatment, innovative research, and rigorous education. With strengths across solid tumors, hematologic malignancies, and stem cell transplantation, the Division offers comprehensive care and leads cutting-edge research spanning basic science to population health. Faculty are deeply committed to mentoring the next generation of physician-scientists while delivering the highest quality cancer care.
Research
The Division of Malignant Hematology and Medical Oncology drives nationally recognized basic, translational, clinical, and population-based research to advance the understanding, diagnosis, and treatment of cancer and blood disorders. With more than 300 research and clinical faculty, the UPMC Hillman Cancer Center—one of only 57 NCI-designated comprehensive cancer centers—serves as a hub for groundbreaking discoveries and innovative clinical trials. Division faculty play leading roles across major research programs, advancing progress across the full spectrum of cancer science and care.
>> Read more
Education and Training
The Division is committed to training future cancer researchers and clinical leaders through comprehensive education and transformative research under world-class mentorship. The Hematology/Oncology Fellowship offers individualized training that fosters leadership, while postdoctoral fellows engage in groundbreaking research across disciplines, supported throughout their careers by a strong culture of mentorship, collaboration, and professional development.
>> Read more
>> Hematology/Oncology Fellowship Program
>> ASH Hematology Fellowship Program
>> Oncology Research Training
Patient Care
Aligned with UPMC Hillman Cancer Center, the Division of Malignant Hematology and Medical Oncology is internationally recognized for excellence in cancer prevention, diagnosis, and treatment, delivering advanced, personalized care across UPMC hospitals and clinics. Integrating evidence-based pathways with innovative therapies, the Division combines multidisciplinary expertise and research to serve patients with all cancer types. >> Read more
News and Events
Renowned Hematologic Oncologist Dr. John C. Byrd Named Director of UPMC Hillman Cancer Center
With a distinguished career advancing blood cancer research and patient care, Byrd will join the Division of Malignant Hematology and Medical Oncology and lead all cancer-related research at UPMC and the University of Pittsburgh, beginning November 2025.
New Gift Will Accelerate Breakthroughs in Sarcoma Research by DOM Faculty
The new Dr. John A. Shoener Family Endowed Research Fund for Sarcoma will support studies aimed at improving outcomes for this understudied group of cancers.
Donate to the Division of
Malignant Hematology and Medical Oncology
Your philanthropic support is essential to help UPMC Hillman Cancer Center continue providing compassionate, cutting-edge care and advancing groundbreaking research that transforms cancer treatment. Every gift helps sustain innovative programs and vital patient support services that make a lasting difference in the fight against cancer.